Board of Directors

Our Board of Directors has extensive drug development and corporate leadership to oversee our global operations.

Guo-Liang Yu, PhD

Guo-Liang Yu, PhD

Co-Founder, Executive Director, Chairman and Chief Executive Officer

Sanjeev Redkar, PhD, MBA

Sanjeev Redkar, PhD, MBA

Co-Founder, Executive Director and President

Kenneth Carter, PhD

Kenneth Carter, PhD

Independent Director
Compensation Committee, Audit Committee

Moses Chen, PhD

Moses Chen, PhD

Independent Director
Governance Committee, Compensation Committee

Wendy Hayes CPA, MBA

Wendy Hayes, CPA, MBA

Independent Director
Audit Committee, Compensation Committee

Glenn S. Vraniak, MBA

Glenn Vraniak, MBA

Independent Director
Audit Committee, Governance Committee

Robert (Bob) Lin, MD, PhD

Robert Lin, MD, PhD

Independent Director
Governance Committee

Board Diversity Matrix for Apollomics Inc.
As of March 28, 2024
Country of Principal Executive Offices United States
Foreign Private Issuer Yes
Disclosure Prohibited Under Home Country Law No
Total Number of Directors 7
Female Male Non-Binary Did Not Disclose Gender
Part I: Gender Identity
Directors 1 6 N/A N/A
Part II: Demographic Background
Underrepresented Individual in Home Country Jurisdiction 5
LGBTQ+ N/A
Did Not Disclose Demographic Background N/A